Salesforce (CRM)
(Delayed Data from NYSE)
$264.00 USD
+5.41 (2.09%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $264.49 +0.49 (0.19%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$264.00 USD
+5.41 (2.09%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $264.49 +0.49 (0.19%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
Zacks News
A Closer Look at Retail and Nvidia Earnings
by Sheraz Mian
Nvidia has established itself as a true leader of the coming artificial intelligence (AI) economy, with its next set of results scheduled to come after the market's close on Wednesday, August 28th. What can investors expect?
Unveiling Salesforce.com (CRM) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Salesforce.com (CRM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2024.
Should You Buy, Sell or Hold Salesforce (CRM) Ahead of Q2 Earnings?
by Anirudha Bhagat
The growing adoption of generative AI-enabled solutions and the continued cloud migration are likely to have aided Salesforce's (CRM) Q2 performance.
Salesforce.com (CRM) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Salesforce.com (CRM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Salesforce.com (CRM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Salesforce.com (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoom Video (ZM) Upgrades Webinars to Host 1 Million Attendees
by Zacks Equity Research
Zoom Video (ZM) upgrades its Zoom Webinars with a single-use webinar offering, which can host up to one million attendees.
Salesforce.com (CRM) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) concluded the recent trading session at $265.38, signifying a +0.94% move from its prior day's close.
Salesforce (CRM) Dips 8% in 3 Months: What Should Investors Do Now?
by Anirudha Bhagat
Given Salesforce's (CRM) decelerating sales growth amid softening IT spending along with competitive pressure, it is prudent to stay away from investing in the stock right now.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Salesforce.com (CRM) Stock Moves -0.48%: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) reachead $251.31 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.
Salesforce.com (CRM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $238.42, indicating a -0.25% shift from the previous trading day.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is First Trust Dow 30 Equal Weight ETF (EDOW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EDOW
Upland Software (UPLD) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Upland Software's (UPLD) second-quarter fiscal 2024 performance is likely to have benefited from increased customer acquisitions and successful AI integrations.
Salesforce.com (CRM) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Salesforce.com (CRM) concluded the recent trading session at $258.59, signifying a -1.57% move from its prior day's close.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Salesforce (CRM) Rises 6% in a Week: What Should Investors Do Now?
by Anirudha Bhagat
While Salesforce's (CRM) recent stock surge and strong market position are encouraging, slowing sales growth warrants caution.
Workday (WDAY), Salesforce Unite to Enhance Workplace Efficiency
by Zacks Equity Research
Workday (WDAY) and Salesforce collaborate to unveil an advanced AI service agent poised to redefine workplace efficiency and employee support.
Here's Why Salesforce.com (CRM) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Salesforce.com (CRM) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $256.06, moving +0.78% from the previous trading session.
Wall Street Analysts See Salesforce.com (CRM) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DocuSign (DOCU) Dips 12% in 6 Months: Is the Stock Worth Buying?
by Shuvra Shankar Dey
Given the recent decline in DocuSign (DOCU) shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity at this time.
Salesforce.com (CRM) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $251.22, marking a -1.88% move from the previous day.
Dropbox (DBX) Up 8.4% in a Month: How Should You Play the Stock?
by Aniruddha Ganguly
Dropbox's (DBX) strong prospects, driven by an expanding AI-powered portfolio, as well as a solid partner base, make it a long-term pick.
Company News for Jul 15, 2024
by Zacks Equity Research
Companies in The News Are: BK,T,CRM,TXN